Join our Community
Support ToI and remove all ads
Learn more
English
العربية
Français
فارسی
עברית
Get The Daily Edition
Account
Sign In
search
search
Home
Israel & the Region
Jewish Times
Israel Inside
The Blogs
Startup Israel
Newsletters
The Daily Edition
What Matters Most Today
Startup Daily
Updates from Silicon Wadi
The Weekend Edition
The Best Reads of the Week
Weekly Highlights
Choice Voices From The Blogs
Battling COVID
Weekly Update
Partners
Atlanta
Atlanta Jewish Times
New York
The Jewish Week
North New Jersey
The Jewish Standard
Pittsburgh
Jewish Chronicle
United Kingdom
The Jewish News
Australia
The Australian Jewish News
For Publishers
Become a Partner
Community
Join our community
Sign in
About The Times of Israel
Advertise on The Times of Israel
Contact us
Get the Daily Edition
submit
Follow us
Facebook
Twitter
© 2020 The Times of Israel , All Rights Reserved
Terms and conditions
Privacy policy
search
MARILYNN MARCHIONE
January 19, 2021, 8:53 am
A new COVID-19 challenge: Mutations rise along with cases
Each new infection gives the virus a chance to mutate as it makes copies of itself, threatening to undo the progress made so far to control the pandemic
By
MARILYNN MARCHIONE
December 21, 2020, 3:01 am
How worried do we need to be about new coronavirus strains?
As a new, highly infectious strain sweeps across the UK, experts say that at this stage it’s unlikely it will undermine the vaccines
By
MARILYNN MARCHIONE
December 8, 2020, 9:25 pm
Trial results show AstraZeneca coronavirus vaccine 70% effective
But questions remain about ability to protect those over 55; health officials around the world hope to rely on shot because of its low cost, availability and ease of use
By
MARILYNN MARCHIONE
November 22, 2020, 5:04 am
US regulator gives emergency approval to antibody drug used on Trump
FDA allows use of experimental Regeneron treatment for COVID-19 patients at high risk of developing severe illness
By
MARILYNN MARCHIONE
October 30, 2020, 7:45 pm
Study testing COVID antibody drug used to treat Trump halted for some patients
Regeneron Pharmaceuticals says it will stop enrolling seriously ill patients, who need intense oxygen treatment or breathing machines, in trial over safety concerns
By
MARILYNN MARCHIONE
October 23, 2020, 6:46 am
FDA approves first COVID-19 drug: antiviral remdesivir
Medicine found to cut recovery time by five days on average, but no studies have shown it improves chances of surviving the coronavirus
By
MARILYNN MARCHIONE
October 8, 2020, 3:02 am
Ethicists say Trump special treatment raises fairness issues
US resident given rare access to experimental drug; questions also raised as to quality of treatment, with many details on his condition withheld from public
By
MARILYNN MARCHIONE
October 3, 2020, 3:51 am
Trump gets experimental drug aimed at curbing severe illness
Antibody cocktail is in late-stage testing and its safety and effectiveness are not yet known, but maker Regeneron says it might reduce the period symptoms last
By
MARILYNN MARCHIONE
October 2, 2020, 9:19 pm
Trump’s age, health woes raise his risk level in COVID-19 illness
At 74, president’s age would be the primary risk factor, says infectious disease expert; Trump’s also obese, with a BMI over 30, which lowers immunity to virus
By
MARILYNN MARCHIONE
September 27, 2020, 8:18 pm
Million who died of COVID-19 also illuminated treatment
Many more deaths expected as infections surge in US and elsewhere, but there are signs death rate is declining, partially due to hard-fought medical advances
By
MARILYNN MARCHIONE
September 16, 2020, 6:43 pm
Study suggests antibody drug may cut COVID-19 hospitalizations
While tests of drug fell short of main goals, Eli Lilly says results hinting fewer people with virus may need to be hospitalized are an encouraging ‘proof of principle’
By
MARILYNN MARCHIONE
July 30, 2020, 9:09 am
Scientists get closer to blood test for Alzheimer’s disease
Testing identifies people with disease with accuracy ranging from 89% to 98%, but scientists warn new approach still needs more validation
By
MARILYNN MARCHIONE
July 23, 2020, 5:42 am
Coronavirus antibodies fade fast, but protection may last longer
Initial research shows blood cells remember how to efficiently make new antibodies in case of reinfection, meaning someone can have immunity even without antibodies
By
MARILYNN MARCHIONE
July 8, 2020, 10:18 am
‘Desperation science’ slows the hunt for coronavirus medicine
Ironically, attempts to fast-track research on COVID-19 drugs have led to a slew of low-quality studies that add to confusion. And statements by politicians aren’t helping either
By
MARILYNN MARCHIONE
June 5, 2020, 6:42 am
Experts say Floyd’s health issues don’t affect homicide ruling
Autopsy report on George Floyd finds severe heart disease, drugs in system, which would have made reaction to stress more severe, but not caused death, medical reviewers say
By
MARILYNN MARCHIONE
Load More